CHRS
Coherus BioSciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$266.06M
P/E Ratio
—
EPS
$-1.56
Beta
1.04
52W High
$2.62
52W Low
$0.71
50-Day MA
$1.73
200-Day MA
$1.51
Dividend Yield
—
Profit Margin
398.40%
Forward P/E
41.15
PEG Ratio
0.00
About Coherus BioSciences Inc
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $42.17M |
| Gross Profit (TTM) | $28.36M |
| EBITDA | $-172.51M |
| Operating Margin | -339.50% |
| Return on Equity | 33.10% |
| Return on Assets | -31.20% |
| Revenue/Share (TTM) | $0.36 |
| Book Value | $0.50 |
| Price-to-Book | 4.28 |
| Price-to-Sales (TTM) | 6.31 |
| EV/Revenue | 3.059 |
| EV/EBITDA | 1.28 |
| Quarterly Earnings Growth (YoY) | -75.50% |
| Quarterly Revenue Growth (YoY) | 64.90% |
| Shares Outstanding | $149.89M |
| Float | $134.70M |
| % Insiders | 15.31% |
| % Institutions | 33.70% |
Historical Volatility
HV 10-Day
63.95%
HV 20-Day
55.00%
HV 30-Day
61.40%
HV 60-Day
74.89%
HV Rank
4.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($6.75 target)
1
Strong Buy4
Buy1
HoldData last updated: 5/1/2026